Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (16)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. CUNNINGHAM ; M. EVANS-BROWN ; M. FERRI ; D. HEDRICH ; A. NOOR |May 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and in[...]
Article : Périodique
I. GIRAUDON ; D. HEDRICH ; A. PIRONA ; A. NOOR ; J. MOUNTENEY |FRANÇAIS : Avec au moins 9 100 overdoses, ou décès provoqués par la drogue, en Europe en 2016 - en augmentation de 4% depuis 2015 - la consommation de drogues illicites représente un véritable défi de santé public (EMCDDA European Drug Report 2[...]
Rapport
OEDT = EMCDDA ; I. GIRAUDON ; F. MATHIS ; D. HEDRICH ; J. VICENTE ; A. NOOR | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]
Rapport
OEDT = EMCDDA ; I. GIRAUDON ; A. M. DINES ; N. SINGLETON ; A. NOOR ; P. I. DARGAN ; D. WOOD | Lisbon : OEDT / EMCDDA | Technical reports | 2020ENGLISH: This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of th[...]
Chapitre
R. UDRISARD ; C. GRIFFITHS ; P. ESSEIVA ; F. ZOBEL ; T. GROSHKOVA ; A. NOOR | 2023Both policymakers and the public are interested in the size of the drug market. However, often both the origin and the veracity of estimates made in this area are unclear. To help understand this topic, this chapter summarizes the findings from [...]Nouveauté
Article : Périodique
D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR |In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Roman[...]
Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]
Article : Périodique
P. GRIFFITHS ; D. LOPEZ ; R. SEDEFOV ; A. GALLEGOS ; B. HUGHES ; A. NOOR ; L. ROYUELA |AIM OF THE STUDY: To review the information available on the use of khat (Catha edulis) in the EU, and to assess the future use of this drug and related substances. MATERIAL AND METHODS: Khat is not controlled by international law and it has not[...]
Rapport
OEDT = EMCDDA ; D. THANKI ; J. MATIAS ; P. GRIFFITHS ; A. NOOR ; D. OLSZEWSKI ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported da[...]
Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]
Article : Périodique
C. CARPENTIER ; L. ROYUELA ; A. NOOR ; D. HEDRICH |The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has been collecting aggregated data on illicit drug use among European prison populations for over a decade. Additional studies were identified in a literature search. Together[...]
Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; R. SEDEFOV ; A. NOOR ; J. VICENTE ; R. SIMON |Aim: A central task for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is to produce an annual report of the latest data available on drug demand and drug supply in Europe. This paper is intended to facilitate a better unde[...]
Article : Périodique
J. MATIAS ; E. KALAMARA ; F. MATHIS ; K. SKARUPOVA ; A. NOOR ; N. SINGLETON |Background: Most comparative drug policy analyses utilise measures of drug use, often from general population surveys (GPS). However, the limitations of GPS are well-recognised, including the small numbers of people who use illicit drugs sampled[...]
Document texte divers
A. PIRONA ; A. NOOR ; G. BURKHART ; Lisbon Addictions Conference 2015 (23-25 September 2015; Lisbon) | Lisbon : OEDT / EMCDDA | 2015The need for a more accurate depiction of how Europeans consume cannabis, which includes simultaneous use of tobacco, is urgently required in our monitoring and screening tools in order to achieve an accurate assessment of the associated addicti[...]
Rapport
OEDT = EMCDDA ; L. MONTANARI ; B. GUARITA ; A. NOOR ; L. WIESSING ; F. GOMES ; D. HEDRICH ; A. PIRONA ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Manuals | 2012FRANÇAIS : L'indicateur de demande de traitement, ou TDI (Treatment Demand Indicator), a été établi en 2000 à partir des travaux du groupe de coopération du Conseil de l'Europe pour la lutte contre l'abus et le trafic de drogues (Groupe Pompido[...]
